Cantitate/Preț
Produs

Biopharmaceuticals, an Industrial Perspective

Editat de G. Walsh, B. Murphy
en Limba Engleză Paperback – 15 dec 2010
Biopharmaceuticals, an Industrial Perspective provides a unique and up-to-date insight into the biopharmaceutical industry. Largely written by industrial authors, its scope is multidisciplinary. Several chapters overview the production and medical applications of specific biopharmaceuticals. Other chapters detail additional relevant issues, including the stabilisation of biopharmaceutical products, EU biopharmaceutical regulatory affairs and biopharmaceutical patent law. A series of four chapters reviews important validation issues as applied to biopharmaceutical manufacturing. Additional issues considered include biopharmaceutical information technology as well as viral and non-viral gene therapy.
The book is of particular relevance to scientists and allied professionals already employed in the biopharmaceutical industry, or to those seeking employment within this industry. Its scope also renders it an ideal reference source for students undertaking advanced undergraduate or postgraduate courses in biotechnology, pharmaceutical science, biochemistry or medicine.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 175749 lei  6-8 săpt.
  SPRINGER NETHERLANDS – 15 dec 2010 175749 lei  6-8 săpt.
Hardback (1) 176355 lei  6-8 săpt.
  SPRINGER NETHERLANDS – 30 sep 1999 176355 lei  6-8 săpt.

Preț: 175749 lei

Preț vechi: 214328 lei
-18% Nou

Puncte Express: 2636

Preț estimativ în valută:
33636 35484$ 28031£

Carte tipărită la comandă

Livrare economică 02-16 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789048152377
ISBN-10: 9048152372
Pagini: 528
Ilustrații: X, 514 p.
Dimensiuni: 160 x 240 x 30 mm
Greutate: 0.74 kg
Ediția:Softcover reprint of hardcover 1st ed. 1999
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

Biopharmaceuticals, an overview.- Abciximab: The First Platelet Glycoprotein IIb/IIIa Receptor Antagonist.- Recombinant Coagulation Factor IX (BeneFix®).- Biopharmaceutical Drug Development: A Case History.- Follitropin beta (Puregon).- Insulin Lispro (Humalog).- Interferon beta-1b — the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS).- Reteplase, a recombinant plasminogen activator.- Stabilisation of biopharmaceutical products and finished product formulations.- Patent Law for Biopharmaceuticals.- The development of new medicines: an overview.- The EMEA and regulatory control of (bio)pharmaceuticals within the European Union.- Biopharmaceutical Validation: an overview.- Validation of Biopharmaceutical Chromatography Systems.- Validation of Water for Injections (WFI) for Biopharmaceutical Manufacture.- Information retrieval and the biopharmaceutical industry: an introductory overview.- Information technology and the internet as a resource of biopharmaceutical information.- Marketing Issues for the (Bio)pharmaceutical sector.- Viral mediated gene therapy.- Pharmaceutical gene medicines for non-viral gene therapy.